# STATUS

> **Rewritten** every session. Describes **now**, never history — history lives in
> `JOURNAL.md`. Hard cap: 60 lines. If it exceeds that, you are logging, not stating.

**Updated:** 2026-09-16 · **Phase:** Phase 2L Complete · **Health:** green

## Where we are

Phase 2L (ADR-0011 Evaluation Subsystem) is complete, accepted by the Official PM, and squash-merged into `main` at `23e920e` (PR #61, Issue #60).

- Evaluation runtime substrate implemented in `cv_agent/evaluation/` with authoritative empirical benchmark execution, strict ADR-0005 transport delegation, and mandatory external `ToolId`.
- Authorization propagation originates strictly from verified ADR-0003 credentials (`approval_authorized`), with zero local assertion or identity synthesis.
- Hardware-synchronized timing validation enforced per ADR-0011 §3.13 both on observation paths and at the immutable `BenchmarkResult` contract boundary (zero defaults, unsynchronized modes rejected).
- Direct raw benchmark ingestion path in `DefaultEvaluationRunner` validates via contract and plan target requirements with zero bypass.
- All 46 adversarial boundary tests pass; full test suite reaches 508 passing tests.
- CI completed cleanly on GitHub Actions run `35123638631` across Python 3.10–3.13 matrix.

## In flight

| Item | Issue | PR | State |
|---|---|---|---|
| Phase 2M Optimization & Deployment Subsystem (ADR-0012) | TBD | TBD | Queued; awaiting issue and work branch initialization |

## Next 3 actions

1. Initialize Phase 2M tracking issue and cut `feature/<owner>/phase-2m-optimization-deployment` branch from `main`.
2. Implement ADR-0012 Optimization & Deployment Subsystem runtime package (`cv_agent/optimization/` or equivalent).
3. Construct adversarial boundary test suite covering INT8 calibration leakage, shape profiles, and deployment rollbacks.

## Blockers

- None. Phase 2L is complete and all quality gates are green on `main`.

## Scope guard

Evaluation owns immutable evaluation specifications, empirical metric/benchmark semantics, baseline comparison, diagnostics, and reproducibility result construction. It does NOT own orchestration lifecycle/approval/recovery (ADR-0003), physical transport (ADR-0005), experiment persistence (ADR-0004), dataset authority (ADR-0009), checkpoint/training authority (ADR-0010), or cognitive strategy (ADR-0008).
